Goldman Sachs: Major Banks' Second Round of Capital Injection Nearing Completion, Favoring CCB and Bank of China
nashnova research
ICBC announced a RMB 100 billion private placement, closing the Ministry of Finance-led capital injection into China's five largest banks; Goldman sees the move as a balance-sheet reinforcement — not a lending accelerant — and prefers CCB and Bank of China.
Where does ICBC's RMB 100 billion come from?
ICBC announced an A-share private placement of RMB 100 billion on September 6 — RMB 70 billion from the Ministry of Finance and RMB 30 billion from China Tobacco.
This is the final tranche of the MoF's recapitalization of all five major banks since 2025.
This means → the MoF borrows via special government bonds, injects the cash for equity, and earns a ~3%–4% dividend yield — well above the 1.68% yield on 10-year government bonds.
How much dilution do shareholders face?
Goldman estimates that under a static scenario using the 20-day average A-share price, ICBC's 2026 EPS dilution (earnings per share — the profit each share represents) is roughly 3.5%, and book-value dilution about 1.6%.
Yet Goldman forecasts ICBC's 2026–28 EPS CAGR at 5% and book-value CAGR at 7%.
In plain terms = per-share profit dips briefly, but earnings growth should recover the gap within roughly two years.
All five banks also raised their payout ratio from 30% to 31%, implying about 3% dividend-per-share growth.
Will the banks lend more now?
Goldman's answer: no meaningful acceleration. The four banks that completed injections earlier in 2025 showed no pick-up in loan growth afterward.
This reflects a core constraint: what holds banks back is weak credit demand, not insufficient capital.
Macquarie's chief China economist Hu Weijun echoed the point, calling the near-term economic impact "extremely limited."
This means → the real purpose is thickening the safety cushion — loss absorption and optionality for future expansion — not an immediate economic stimulus.
Why was the injection smaller than expected?
A Citi analyst noted the scaled-down plan highlights that Chinese insurers' capital positions are relatively healthy, reducing the urgency for large-scale recapitalization.
In plain terms = the banks were never so short of capital that they needed a massive transfusion — hence the final figure came in below market expectations.
Which stocks does Goldman prefer — and which does it avoid?
Top picks: CCB (00939) and Bank of China (03988), both rated Buy with H-share targets of HK$10.1 and HK$5.96 respectively.
Postal Savings Bank (01658) is also a Buy at HK$5.76; ICBC is rated Neutral at HK$6.92.
Bank of Communications (03328) is the sole Sell, target HK$6.39.
Among regional banks, Goldman favors Bank of Ningbo (002142.SZ).
What does this mean for the sector as a whole?
Goldman says the recapitalization reinforces its constructive sector view: large banks are expected to keep outperforming smaller peers.
The critical variable remains whether credit demand can stage a meaningful recovery — that is the real test of the thesis.
This means → capital injections solve the "can they lend?" question; "does anyone want to borrow?" is the switch that actually determines bank earnings trajectories.
市场有风险，内容仅供研究参考，不构成投资建议。